Evolving Treatments for Schizophrenia

In this CME podcast, Dr. Andrew Cutler interviews Dr. Jonathan Meyer about the history of muscarinic receptor science in schizophrenia and how that informs the mechanisms of action of novel muscarinic-targeting drugs for this disorder. They also discuss the efficacy and safety of these drugs and provide practical strategies for prescribing xanomeline-trospium.  

Create a free NEI guest account and obtain CME/CE by participating in this activity here: https://nei.global/e242-cme 

Never miss an episode!🎙SUBSCRIBE to the NEI Podcast– available on all your favorite platforms: https://nei.global/podcast 

Interested in Psychopharmacology?  Learn about the NEI Master Psychopharmacology Program: https://nei.global/mpp  

Stay updated with email alerts and join our conversations on social. Follow us on: 

• YouTube: https://nei.global/youtube 

• Instagram: https://nei.global/instagram 

• LinkedIn: https://nei.global/linkedin 

• Facebook: https://nei.global/facebook 

• X: https://nei.global/twitter